Reserfia
Reserfia Brand names, Reserfia Analogs
- Cam-Ap-Es
- Demi-Regroton
- Diupres-250
- Diupres-500
- Diutensen-R
- Dralserp
- Hiserpia
- Hydrap-ES
- Hydromox R
- Hydroserpine Plus (R-H-H)
- Metatensin #2
- Metatensin #4
- Naquival
- Novoreserpine
- Rau-Sed
- Regroton
- Renese-R
- Reserfia
- Salutensin
- Salutensin-Demi
- Sandril
- Ser-A-Gen
- Serpalan
- Serpalan (TN)
- Serpanray
- Serpasil
- Serpasil-Apresoline
- Serpasil-Esidrix #1
- Serpasil-Esidrix #2
- Serpate
- Serpivite
- Unipres
Reserfia Brand Names Mixture
- Hydropres 25 Tab (Hydrochlorothiazide + Reserpine)
- Hydropres 50 Tab (Hydrochlorothiazide + Reserpine)
- SER-AP-ES Tab (Hydralazine Hydrochloride + Hydrochlorothiazide + Reserpine)
Reserfia Chemical_Formula
C33H40N2O9
Reserfia RX_link
No information avaliable
Reserfia fda sheet
Reserfia msds (material safety sheet)
Reserfia Synthesis Reference
No information avaliable
Reserfia Molecular Weight
608.679 g/mol
Reserfia Melting Point
264.5 oC
Reserfia H2O Solubility
73 mg/L
Reserfia State
Solid
Reserfia LogP
3.32
Reserfia Dosage Forms
Tablets
Reserfia Indication
Foe the treatment of hypertension
Reserfia Pharmacology
Reserpine is an adrenergic blocking agent used to treat mild to moderate hypertension via the disruption of norepinephrine vesicular storage. The antihypertensive actions of Reserpine are a result of its ability to deplete catecholamines from peripheral sympathetic nerve endings. These substances are normally involved in controlling heart rate, force of cardiac contraction and peripheral resistance.
Reserfia Absorption
No information avaliable
Reserfia side effects and Toxicity
Possible human carcinogen. May cause reproductive harm. ORL-RAT LD50 420 mg/kg; IPR-RAT LD50 44 mg/kg; IVN-RAT LD50 15 mg/kg; ORL-MUS LD50 200 mg/kg; SCU-MUS LD50 52 mg/kg; IPR-RBT LD50 7 mg/kg
Reserfia Patient Information
No information avaliable
Reserfia Organisms Affected
Humans and other mammals
